JPH0453846B2 - - Google Patents

Info

Publication number
JPH0453846B2
JPH0453846B2 JP57204428A JP20442882A JPH0453846B2 JP H0453846 B2 JPH0453846 B2 JP H0453846B2 JP 57204428 A JP57204428 A JP 57204428A JP 20442882 A JP20442882 A JP 20442882A JP H0453846 B2 JPH0453846 B2 JP H0453846B2
Authority
JP
Japan
Prior art keywords
formula
imidazolidinylidene
dichloro
imidazoline
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP57204428A
Other languages
English (en)
Japanese (ja)
Other versions
JPS58116417A (ja
Inventor
Maarei Yooku Juniaa Birii
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alcon Vision LLC
Original Assignee
Alcon Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Laboratories Inc filed Critical Alcon Laboratories Inc
Publication of JPS58116417A publication Critical patent/JPS58116417A/ja
Publication of JPH0453846B2 publication Critical patent/JPH0453846B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/44—Nitrogen atoms not forming part of a nitro radical
    • C07D233/50—Nitrogen atoms not forming part of a nitro radical with carbocyclic radicals directly attached to said nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fertilizers (AREA)
JP57204428A 1981-11-20 1982-11-20 眼内圧を低下する方法 Granted JPS58116417A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US32336981A 1981-11-20 1981-11-20
US323369 1981-11-20

Publications (2)

Publication Number Publication Date
JPS58116417A JPS58116417A (ja) 1983-07-11
JPH0453846B2 true JPH0453846B2 (en, 2012) 1992-08-27

Family

ID=23258921

Family Applications (1)

Application Number Title Priority Date Filing Date
JP57204428A Granted JPS58116417A (ja) 1981-11-20 1982-11-20 眼内圧を低下する方法

Country Status (6)

Country Link
EP (1) EP0081924B1 (en, 2012)
JP (1) JPS58116417A (en, 2012)
AT (1) ATE18006T1 (en, 2012)
CA (1) CA1201066A (en, 2012)
DE (1) DE3269242D1 (en, 2012)
NL (1) NL950008I2 (en, 2012)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2549049B1 (fr) * 1983-07-13 1986-06-20 Chauvin Blache Lab Nouvelles amidines, leur procede de preparation et leur application therapeutique
EP0236636A3 (en) * 1986-02-07 1988-12-07 Alcon Laboratories, Inc. Use of clonidine derivatives for the preparation of ocular hemostatic agents
FR2592042B1 (fr) * 1985-12-19 1988-03-25 Ile De France Nouveaux ortho-anisamides, leur procede d'obtention, et leurs applications therapeutiques
US4801617A (en) * 1987-04-06 1989-01-31 Leclerc Gerard Iminoimidazolidines useful in lowering intraocular pressure
US5304569A (en) * 1989-11-13 1994-04-19 Orion-Yhtyma Oy Compositions and their use in lowering intraocular pressure
US5124154A (en) * 1990-06-12 1992-06-23 Insite Vision Incorporated Aminosteroids for ophthalmic use
US5340572A (en) * 1993-02-08 1994-08-23 Insite Vision Incorporated Alkaline ophthalmic suspensions
DE19514579A1 (de) 1995-04-20 1996-10-24 Boehringer Ingelheim Kg Verwendung von alpha¶1¶¶L¶-Agonisten zur Behandlung der Harninkontinenz
US6602897B2 (en) 2000-10-14 2003-08-05 Boehringer Ingelheim Pharma Kg m-Amino-phenylimino-imidazolidine derivatives for treating urinary incontinence
IL155338A0 (en) * 2000-10-14 2003-11-23 Boehringer Ingelheim Pharma Novel m-amino-phenylimino-imidazolidine derivatives for treating urinary incontinence
CN100335053C (zh) * 2005-02-18 2007-09-05 山东鲁抗辰欣药业有限公司 一种药物制剂及其制备方法
GB2466622A (en) * 2008-12-23 2010-06-30 Trinity College Dublin Alpha2-Adrenoceptor Ligands

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3636219A (en) * 1964-03-02 1972-01-18 Du Pont Anticholinergic compositions containing certain thiazolines or imidazolines
DE1670274A1 (de) * 1966-10-31 1970-07-16 Boehringer Sohn Ingelheim Neues Verfahren zur Herstellung von 2-Arylamino-1,3-diazacycloalkenen-(2)
AT285599B (de) * 1968-06-21 1970-11-10 Boehringer Sohn Ingelheim Verfahren zur Herstellung von neuen trisubstituierten 2-Arylaminoimidazolinen und ihren Salzen
BE759125A (fr) * 1969-11-19 1971-05-18 Boehringer Sohn Ingelheim Nouvelles n-allyl-2-arylamino-imidazolines-(2) substituees et procedes pour les fabriquer
BE759126A (fr) * 1969-11-19 1971-05-18 Boehringer Sohn Ingelheim Nouvelles n-cycloalcoyl-arylamino-imidazolines-(2) substituees et procedes pour les fabriquer
GB1595412A (en) * 1976-12-14 1981-08-12 Boots Co Ltd Method for control of pests attacking animals
DE2806811A1 (de) * 1978-02-17 1979-08-23 Boehringer Sohn Ingelheim Neue substituierte 2-phenylimino- imidazolidine, deren saeureadditionssalze, diese enthaltene arzneimittel und verfahren zur herstellung derselben
DE2806775A1 (de) * 1978-02-17 1979-08-30 Boehringer Sohn Ingelheim Neue substituierte 2-phenylimino- imidazolidine deren saeureadditionssalze, diese enthaltende arzneimittel und verfahren zur herstellung derselben
US4287201A (en) * 1980-03-03 1981-09-01 Merck & Co., Inc. Anovulatory method and chicken feed compositions
EP0043659B1 (en) * 1980-07-09 1985-02-06 Beecham Group Plc Clonidine derivatives useful in the treatment of diarrhoea

Also Published As

Publication number Publication date
CA1201066A (en) 1986-02-25
EP0081924B1 (en) 1986-02-19
DE3269242D1 (en) 1986-03-27
NL950008I2 (nl) 1996-12-02
ATE18006T1 (de) 1986-03-15
EP0081924A1 (en) 1983-06-22
JPS58116417A (ja) 1983-07-11
NL950008I1 (nl) 1995-06-16

Similar Documents

Publication Publication Date Title
US4515800A (en) Method of lowering intraocular pressure using phenylimino-imidazoles
JP2977536B2 (ja) フェニル−及びアミノフェニル−アルキルスルホンアミド及び尿素誘導体
JPH0545584B2 (en, 2012)
US4517199A (en) Method for lowering intraocular pressure using phenylimino-imidazoles
EP0008653B1 (de) N-Substituierte Benzimidazole, Verfahren zu ihrer Herstellung, und sie enthaltende Arzneimittel
CH630359A5 (de) Verfahren zur herstellung von neuen aminoalkylheterocyclen und ihren saeureadditionssalzen.
JPH0453846B2 (en, 2012)
WO1998011062A1 (de) Benzamidinderivate und ihre verwendung als arzneimittel mit ltb4-antagonistischer wirkung
JPH035392B2 (en, 2012)
AU653245B2 (en) Novel benzopyran derivatives
US5231096A (en) Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives
HK9494A (en) Substituted 1-(1h-imidazol-4-yl)alkyl benzamides
JPS6320424B1 (en, 2012)
JPS58501725A (ja) アリ−ルオキシプロパノ−ルアミン誘導体のエステル
US3265691A (en) 1-benzyl-2-aminomethyl-5, 6-dialkoxybenzimidazoles
US4897417A (en) Prodrugs of 3,4-hydroxy benzoyloxypropanolamines
JPS58110556A (ja) 新規なｐ−置換３−フエノキシ−１−カルボニルアミノ−アルキルアミノ−プロパノ−ル−２類
JPH01275585A (ja) ４，５，６，７―テトラハイドロイソチアゾロ〔４，５―ｃ〕ピリジン誘導体及び異性体
CA1194418A (en) 2-(trisubstituted phenylimino)-imidazoline compositions for lowering intraocular pressure
US4082847A (en) Substituted aminoethanols and pharmaceutical use
JPS59130280A (ja) ７−フエニル−７−フエノキシメチル−ヘキサヒドロ−１，４−オキサゼピン、その製法及び用途
US4204069A (en) Reductive alkylation
JPS5826871A (ja) 新規ヘテロアリールオキシプロパノールアミンおよびその製法
KR840000676B1 (ko) N-치환된 헤테로사이클렌의 제조방법
US4558061A (en) Bronchospasmolytic 1-(3-methanesulfonamido-4-hydroxyphenyl)-2-[(3-(4-acyl-aminophenyl)-imidazolidin-2-one-1-yl)-alkylamino]-ethanols